You are here

Roche

Roche’s ‘Brilliant Concept’ Fades Amid Doctor Disappointment

Bloomberg

Wed, 02/23/11 - 08:15 am

Bone Drugs by Merck, Roche, Novartis May Add Leg Fractures

Bloomberg

Tue, 02/22/11 - 05:56 pm

bisphosphonates

Which Sales Reps Rank Highest With Oncologists?

Pharmalot

Tue, 02/22/11 - 10:36 am

Should FDA Hit The Brakes On Accelerated Approval?

Pharmalot

Wed, 02/9/11 - 11:54 am

FDA Says Drug Firms Didn't Finish Follow-Ups

WSJ Online

Wed, 02/9/11 - 11:16 am

New York's Medicaid program gives Roche glucose monitors the boot

Tue, 02/8/11 - 08:12 pm

blood glucose monitoring

Roche's Avastin Successful In Late-Stage Ovarian Cancer Trials

FOX Business

Tue, 02/8/11 - 11:55 am

Roche chief accentuates Avastin's positives

Fierce Pharma

Mon, 02/7/11 - 11:30 am

Value Pharma Stocks in Overpriced Market

Seeking Alpha

Sat, 02/5/11 - 10:59 am

Abbott Laboratories

Bristol-Myers Squibb

Roche Reduces Avastin Forecast as Revenue Declines

Bloomberg

Wed, 02/2/11 - 09:03 am

Roche Said to Return Diabetes Drug Rights to Ipsen

Bloomberg

Tue, 02/1/11 - 08:25 am

Roche’s Tarceva Extends Lives, Study Stopped Early

Bloomberg

Fri, 01/28/11 - 09:41 am

Roche Scores Big With Plexxikon and Immunogen Deals

Seeking Alpha

Tue, 01/25/11 - 09:30 am

personalized medicine

Major Drugmaker Sales Growth to Slow to 1.3%, Datamonitor Says

Bloomberg

Fri, 01/21/11 - 08:00 am

Why Big Pharma Is the New Big Biotech

Seeking Alpha

Fri, 01/21/11 - 07:57 am

Gilead Sciences

Genentech cites chemo comparisons in Avastin appeal

Fierce Pharma

Wed, 01/19/11 - 11:16 am

Biosimilars: Empty Threats?

InVivo

Tue, 01/18/11 - 11:58 am

Roche, Avastin And An Influential Cancer Doc Panel

Pharmalot

Tue, 01/11/11 - 02:41 pm

Medicare contractor won't stop paying for Avastin

Fierce Pharma

Mon, 01/10/11 - 12:40 pm

Pages